Topically Administered Janus-Kinase Inhibitors Tofacitinib and Oclacitinib Display Impressive Antipruritic and Anti-Inflammatory Responses in a Model of Allergic Dermatitis. (Q44858410)
Jump to navigation
Jump to search
scientific article published on 9 July 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Topically Administered Janus-Kinase Inhibitors Tofacitinib and Oclacitinib Display Impressive Antipruritic and Anti-Inflammatory Responses in a Model of Allergic Dermatitis. |
scientific article published on 9 July 2015 |
Statements
Topically Administered Janus-Kinase Inhibitors Tofacitinib and Oclacitinib Display Impressive Antipruritic and Anti-Inflammatory Responses in a Model of Allergic Dermatitis (English)
Tomoki Fukuyama
Sarah Ehling
Elizabeth Cook